Salestools LogoSalestools
Agenti IA Salestools
Soluzioni
Risorse
Azienda
Prezzi
Salestools Logo

Salestools

L'agente IA #1 per team di vendita e Go-to-Market. Vendi di più, più velocemente, con meno sforzo.

Prodotto

  • Agenti di vendita IA
  • Dati di intenzione
  • Dati Tecnologici
  • Tracciamento Visitatori
  • Co-Pilota
  • Vendita Sociale

Soluzioni

  • Servizio Clienti
  • E-commerce
  • SaaS
  • Impresa
  • Piccole Imprese

Risorse

  • Il rapporto
  • Documentazione
  • Riferimento API
  • Centro assistenza
  • Blog
  • Casi studio
  • Webinar

Azienda

  • Chi siamo
  • Carriere
  • Stampa
  • Contatto
  • Partner

Le nostre sedi

  • New York, HQ
  • Bucarest, Laboratorio di Ricerca IA
  • Zug, Svizzera

© 2026 Salestools. Tutti i diritti riservati.

Termini sui Dati e SicurezzaPolitica sulla privacyTermini di servizioAcceptable Use
Tutti i sistemi operativi
Salestools LogoSalestools
Agenti IA Salestools
Soluzioni
Risorse
Azienda
Prezzi
Back to Reports
Fundraising

Modular

Modular Raises $250M in Series C

Palo Alto, CASeptember 24, 20252 min read
Employees
150+

Modular Raises $250M in Series C


Modular has successfully raised $250M in a Series C at a $1.6B valuation led by US Innovative Technology, GV.


Company Overview


Modular is a AI/ML company headquartered in Palo Alto, CA, founded in 2022 with 150+ employees.


AI deployment platform enabling apps to run across diverse chips without rewrites


Fundraising Details


  • Amount Raised: $250M
  • Round Type: Series C
  • Valuation: $1.6B
  • Date: 2025-09-24
  • Investors: US Innovative Technology, GV

About Modular


AI deployment platform enabling apps to run across diverse chips without rewrites The company is positioned in the AI/ML sector, serving a growing market with innovative solutions.


Key Information


  • Headquarters: Palo Alto, CA
  • Founded: 2022
  • Team Size: 150+
  • Industry: AI/ML

What This Means


This funding round demonstrates strong investor confidence in Modular's vision and execution. The capital will likely be used to:


  • Scale Operations: Expand the team and operational capacity
  • Product Development: Enhance existing products and develop new features
  • Market Expansion: Enter new markets and strengthen presence in existing ones
  • Technology Investment: Invest in infrastructure and technology capabilities

Industry Context


The AI/ML sector continues to attract significant investment as companies innovate to meet evolving market demands. Modular's successful fundraising reflects the strong fundamentals and growth potential in this space.


Valuation Milestone


Reaching a $1.6B valuation marks an important milestone for Modular, positioning the company among notable players in the AI/ML industry.


Looking Ahead


With this new capital, Modular is well-positioned to execute on its growth strategy and continue building innovative solutions in the AI/ML space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.


This fundraising news was reported on 2025-09-24. For more information about Modular, visit their headquarters at Palo Alto, CA.

Company Info

Headquarters
Palo Alto, CA
Founded
2022
Team Size
150+

Topics

Fundraising(2912)AI/ML(484)Series C(300)Modular

Share

Related Reports

Fundraising
Tebra

Tebra Raises $250M Growth Financing | Healthcare Practice Management Platform

Healthcare practice management platform Tebra secures $250 million in growth financing led by Hildred Capital for AI-driven automation.

SalesTools Research
SalesTools Research
Jan 12, 2026
0 min read•$250M
Fundraising
Harmattan AI

Harmattan AI Raises $200M Series B | Defense Tech Unicorn at $1.4B Valuation

French defense tech company Harmattan AI secures $200 million Series B led by Dassault Aviation, reaching unicorn status.

SalesTools Research
SalesTools Research
Jan 11, 2026
0 min read•$200M
Fundraising
AirNexis Therapeutics

AirNexis Therapeutics Raises $200M Series A | Novel COPD Treatment

Biotech AirNexis Therapeutics emerges from stealth with $200 million Series A for dual PDE3/4 inhibitor COPD therapy.

SalesTools Research
SalesTools Research
Jan 11, 2026
0 min read•$200M

Turn your sales ideas into reality today

Start your 14-day Pro trial today. No credit card required.

Start building for free